Company news
Nanjing Pharmaceutical Group Company Limited Class A (SSE:600713) news
Nanjing Pharmaceutical Group Company Limited Class A news releases on 6ix. Latest, Jan 10, 2026: Announcement on Redemption of Some Temporarily Idle Raised…
Press releases — page 2
Announcement on Redemption of Some Temporarily Idle Raised Funds Used for Cash Management upon Expiration by the Company and Its Subsidiary
January 9, 2026
Announcement on Interest Payment for Corporate Convertible Bonds in 2025
December 18, 2025
Announcement on Government’s Expropriation of Certain Real Estate and Land of the Company’s Tier-II Subsidiary
December 10, 2025
Announcement on Change of Share Nature and Progress in Reserved Grant under 2025 Restricted Stock Incentive Plan
December 5, 2025
Announcement on Completion of Company Full Name and Registered Capital Change Registration and Filing of the "Articles of Association"
December 3, 2025
Announcement on Outline of the Q3 2025 Performance Briefing
December 1, 2025